Polish company BIOTTS raises PLN 25 million in pre-IPO round
Published
The Polish company BIOTTS, which is developing drug delivery technology based on its own patented platform, announced the success of a funding round ahead of its planned stock market debut. The company raised PLN 25 million.
A pre-IPO round is a stage of financing in which a company raises capital from investors before entering the public market. This allows the company to develop its projects and prepare for listing on the stock exchange.
Drug delivery technology enables more effective transport of active substances into the patient's body. The development of such solutions is important for the pharmaceutical industry, as it can improve the effectiveness of therapies and the comfort of drug use.
The success of this round shows that Polish companies in the biotechnology sector are attracting investor interest. Details regarding the company's further plans and the timing of a possible stock market debut were not provided in the available information.
Sources: MamBiznes.pl
More Poland news
- MG Motor among the top ten car manufacturers in Poland
- Ukrainian anti-drone technologies to be delivered to Poland. Cezary Tomczyk confirms
- Poland Negotiating Over Military Equipment. Ukraine Has Agreed
- Attack in Kraków deepens divisions in Poland, media experts say
- Does Europe Need New Spaces of Solidarity? The Weimar Triangle, Ukraine and the Future of the EU
- After the Shooting in Kraków, Poland Assesses Security Challenges
- Maintenance Poland 2027: Industrial Maintenance Fair to Be Held at Ptak Warsaw Expo
- Poland Prepares Changes to Its Counterterrorism System